Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Syngene International Ltd. ( (IN:SYNGENE) ) has provided an announcement.
Syngene International Ltd. has announced a scheduled meeting with the Life Insurance Corporation of India, set for November 28, 2025, in Mumbai. This meeting, which will be a physical one-on-one interaction, aims to engage with analysts and institutional investors, although no unpublished price-sensitive information will be disclosed. This engagement reflects Syngene’s ongoing efforts to maintain transparency and foster strong relationships with key stakeholders, potentially impacting its market perception positively.
More about Syngene International Ltd.
Syngene International Ltd. operates in the biotechnology industry, providing integrated research, development, and manufacturing services. The company focuses on delivering innovative solutions to global pharmaceutical, biotechnology, and agrochemical sectors, enhancing their research and development capabilities.
Average Trading Volume: 64,839
Technical Sentiment Signal: Sell
Current Market Cap: 253.7B INR
For a thorough assessment of SYNGENE stock, go to TipRanks’ Stock Analysis page.